GASTRIC INTESTINAL METAPLASIA
Clinical trials for GASTRIC INTESTINAL METAPLASIA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC INTESTINAL METAPLASIA trials appear
Sign up with your email to follow new studies for GASTRIC INTESTINAL METAPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 14-Day pill reverse stomach precancer?
Disease control Recruiting nowThis study tests whether the drug pyrvinium can reverse gastric intestinal metaplasia, a condition that raises the risk of stomach cancer. Thirty-two adults with high-risk features will take pyrvinium or a placebo for 14 days. Researchers will compare biopsies before and after tr…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE2 • Sponsor: Katherine Garman • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a common bile acid pill reverse stomach changes that lead to cancer?
Disease control Recruiting nowThis study tests whether ursodeoxycholic acid, a bile acid medication, can reverse gastric intestinal metaplasia—a condition where the stomach lining changes and raises cancer risk. Researchers will give 196 adults without H. pylori infection either the drug or a placebo for 6 mo…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New study aims to stop stomach cancer before it starts
Knowledge-focused Recruiting nowThis study is building a registry of 3,200 people with early changes in the stomach lining that can lead to gastric cancer. Researchers will collect information on lifestyle, diet, and other risk factors through questionnaires. The goal is to better understand why some people dev…
Matched conditions: GASTRIC INTESTINAL METAPLASIA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC